June 15 (Reuters) - Biotron Ltd BIT.AX
* Asx alert-bit225 phase 2 hiv-1 clinical trial update-bit.ax
* Trial headline results anticipated Q3 this year
* Independent data and safety monitoring committee unanimously voted to proceed with second, and larger, cohort at a higher dose Source text for Eikon: ID:nASX8T1wNg Further company coverage: BIT.AX